• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵圆孔未闭封堵术用于预防隐源性卒中的二次发作。

Patent foramen ovale closure for secondary prevention of cryptogenic stroke.

机构信息

Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Expert Rev Cardiovasc Ther. 2021 Mar;19(3):211-220. doi: 10.1080/14779072.2021.1878026. Epub 2021 Feb 19.

DOI:10.1080/14779072.2021.1878026
PMID:33605829
Abstract

: A patent foramen ovale (PFO) is highly prevalent among the adult population. It allows shunting of blood through the inter-atrial septum and has been associated with cryptogenic stroke, transient ischemic attack, platypnea-orthodeoxia syndrome, decompression sickness (e.g. deep-water divers), and migraines.: In this manuscript, we will review the anatomy of PFO with particular emphasis on the factors associated with increased risk of paradoxical embolization, as well as the different modalities for the diagnosis of PFO. We will discuss medical, surgical, and transcatheter therapy for secondary prevention in patients with PFO and cryptogenic stroke, and summarize the data from observational studies, randomized controlled trials (RCTs), and meta-analysis of RCTs that have established the beneficial effect of transcatheter PFO closure in this patient population. Finally, we will provide a brief overview of the role of transcatheter PFO closure in patients with migraine.: Transcatheter closure is the preferred treatment option in young (<60 years) patients with PFO and cryptogenic stroke. A multi-disciplinary approach with input from clinical cardiologist, neurologist, hematologist, cardiac surgeon, and interventional cardiologist provides the best therapeutic plan for each patient taking into account the available data, but also medical, social, and occupational considerations.

摘要

卵圆孔未闭(PFO)在成年人群中高度普遍。它允许血液通过房间隔分流,并与隐源性卒中、短暂性脑缺血发作、反常性呼吸困难-直立性低氧血症综合征、减压病(例如深水潜水员)和偏头痛有关。在本文中,我们将回顾 PFO 的解剖结构,特别强调与反常栓塞风险增加相关的因素,以及诊断 PFO 的不同方式。我们将讨论 PFO 和隐源性卒中患者二级预防的药物、手术和经导管治疗,并总结观察性研究、随机对照试验(RCT)和 RCT 荟萃分析的数据,这些数据证实了经导管 PFO 封堵术在这一患者群体中的有益效果。最后,我们将简要概述经导管 PFO 封堵术在偏头痛患者中的作用。对于年轻(<60 岁)的 PFO 和隐源性卒中患者,经导管封堵是首选治疗方法。临床心脏病专家、神经科医生、血液科医生、心脏外科医生和介入心脏病专家的多学科方法,根据可用数据为每位患者提供最佳治疗方案,但也考虑到医疗、社会和职业因素。

相似文献

1
Patent foramen ovale closure for secondary prevention of cryptogenic stroke.卵圆孔未闭封堵术用于预防隐源性卒中的二次发作。
Expert Rev Cardiovasc Ther. 2021 Mar;19(3):211-220. doi: 10.1080/14779072.2021.1878026. Epub 2021 Feb 19.
2
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.CLOSURE I(评价 STARFlex 间隔封堵系统在因推测性反常栓塞引起的脑卒中和/或短暂性脑缺血发作的卵圆孔未闭患者中的应用)试验中,不明原因卒中合并卵圆孔未闭患者复发性事件的预测因素。
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
3
Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.经导管卵圆孔未闭封堵术与药物治疗复发性血管事件的比较:随机对照试验的系统评价和荟萃分析。
Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Epub 2013 Jul 11.
4
Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.不明原因卒中患者卵圆孔未闭的经皮封堵术——一项更新的综合荟萃分析
Cardiovasc Revasc Med. 2019 Aug;20(8):687-694. doi: 10.1016/j.carrev.2018.09.010. Epub 2018 Sep 19.
5
The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.《隐源性卒中后选择性卵圆孔未闭封堵的病例》
Circ Cardiovasc Interv. 2018 Mar;11(3):e004152. doi: 10.1161/CIRCINTERVENTIONS.117.004152.
6
Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.卵圆孔未闭封堵术与药物治疗隐源性卒中的比较:系统评价和荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16.
7
Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.卵圆孔未闭(PFO)封堵术与药物治疗预防既往不明原因卒中患者复发性卒中的比较:一项随机对照试验的系统评价和荟萃分析
Catheter Cardiovasc Interv. 2018 Jul;92(1):165-173. doi: 10.1002/ccd.27615. Epub 2018 Mar 30.
8
Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.隐源性卒中后卵圆孔未闭封堵术或药物治疗的长期结局:一项随机试验的荟萃分析
Catheter Cardiovasc Interv. 2018 Jul;92(1):176-186. doi: 10.1002/ccd.27636. Epub 2018 May 4.
9
Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.卵圆孔未闭的隐源性卒中患者经皮封堵术与单纯药物治疗的比较:随机对照试验的荟萃分析
Tex Heart Inst J. 2014 Aug 1;41(4):357-67. doi: 10.14503/THIJ-13-3879. eCollection 2014 Aug.
10
Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.隐源性卒中后经导管封堵卵圆孔未闭与药物治疗的比较:一项随机对照试验的荟萃分析
Cerebrovasc Dis. 2018;45(3-4):162-169. doi: 10.1159/000487959. Epub 2018 Mar 29.